Chourasia B, Deshmukh A, Kaur I, Paul G, Panda A, Rathore S
Infect Immun. 2019; 88(2).
PMID: 31712270
PMC: 6977125.
DOI: 10.1128/IAI.00504-19.
Iyer G, Singh S, Kaur I, Agarwal S, Siddiqui M, Bansal A
J Biol Chem. 2018; 293(25):9736-9746.
PMID: 29716996
PMC: 6016463.
DOI: 10.1074/jbc.RA117.001540.
Soni R, Sharma D, Bhatt T
Front Microbiol. 2016; 7:194.
PMID: 26925057
PMC: 4759260.
DOI: 10.3389/fmicb.2016.00194.
Tampaki Z, Mwakubambanya R, Goulielmaki E, Kaforou S, Kim K, Waters A
PLoS One. 2015; 10(3):e0121379.
PMID: 25803874
PMC: 4372514.
DOI: 10.1371/journal.pone.0121379.
Boysen K, Matuschewski K
mBio. 2013; 4(6):e00874-13.
PMID: 24281719
PMC: 3870247.
DOI: 10.1128/mBio.00874-13.
Defining the timing of action of antimalarial drugs against Plasmodium falciparum.
Wilson D, Langer C, Goodman C, McFadden G, Beeson J
Antimicrob Agents Chemother. 2013; 57(3):1455-67.
PMID: 23318799
PMC: 3591904.
DOI: 10.1128/AAC.01881-12.
Expression, characterization, and cellular localization of knowpains, papain-like cysteine proteases of the Plasmodium knowlesi malaria parasite.
Prasad R, Atul , Soni A, Puri S, Sijwali P
PLoS One. 2012; 7(12):e51619.
PMID: 23251596
PMC: 3520923.
DOI: 10.1371/journal.pone.0051619.
Centenary celebrations article: Cysteine proteases of human malaria parasites.
Pandey K
J Parasit Dis. 2012; 35(2):94-103.
PMID: 23024488
PMC: 3235370.
DOI: 10.1007/s12639-011-0084-x.
Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.
Withers-Martinez C, Suarez C, Fulle S, Kher S, Penzo M, Ebejer J
Int J Parasitol. 2012; 42(6):597-612.
PMID: 22543039
PMC: 3378952.
DOI: 10.1016/j.ijpara.2012.04.005.
The malaria parasite progressively dismantles the host erythrocyte cytoskeleton for efficient egress.
Millholland M, Chandramohanadas R, Pizzarro A, Wehr A, Shi H, Darling C
Mol Cell Proteomics. 2011; 10(12):M111.010678.
PMID: 21903871
PMC: 3237080.
DOI: 10.1074/mcp.M111.010678.
Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development.
Boyle M, Wilson D, Richards J, Riglar D, Tetteh K, Conway D
Proc Natl Acad Sci U S A. 2010; 107(32):14378-83.
PMID: 20660744
PMC: 2922570.
DOI: 10.1073/pnas.1009198107.
Apicomplexan parasites co-opt host calpains to facilitate their escape from infected cells.
Chandramohanadas R, Davis P, Beiting D, Harbut M, Darling C, Velmourougane G
Science. 2009; 324(5928):794-7.
PMID: 19342550
PMC: 3391539.
DOI: 10.1126/science.1171085.
Inhibition of malaria parasite development by a cyclic peptide that targets the vital parasite protein SERA5.
Fairlie W, Spurck T, McCoubrie J, Gilson P, Miller S, McFadden G
Infect Immun. 2008; 76(9):4332-44.
PMID: 18591232
PMC: 2519404.
DOI: 10.1128/IAI.00278-08.
Malarial proteases and host cell egress: an 'emerging' cascade.
Blackman M
Cell Microbiol. 2008; 10(10):1925-34.
PMID: 18503638
PMC: 2610400.
DOI: 10.1111/j.1462-5822.2008.01176.x.
Studies on synchronous egress of coccidian parasites (Neospora caninum, Toxoplasma gondii, Eimeria bovis) from bovine endothelial host cells mediated by calcium ionophore A23187.
Behrendt J, Taubert A, Zahner H, Hermosilla C
Vet Res Commun. 2007; 32(4):325-32.
PMID: 18158611
DOI: 10.1007/s11259-007-9033-7.
Falstatin, a cysteine protease inhibitor of Plasmodium falciparum, facilitates erythrocyte invasion.
Pandey K, Singh N, Arastu-Kapur S, Bogyo M, Rosenthal P
PLoS Pathog. 2006; 2(11):e117.
PMID: 17083274
PMC: 1630708.
DOI: 10.1371/journal.ppat.0020117.
Intramembrane proteolysis mediates shedding of a key adhesin during erythrocyte invasion by the malaria parasite.
ODonnell R, Hackett F, Howell S, Treeck M, Struck N, Krnajski Z
J Cell Biol. 2006; 174(7):1023-33.
PMID: 17000879
PMC: 2064393.
DOI: 10.1083/jcb.200604136.
A malarial cysteine protease is necessary for Plasmodium sporozoite egress from oocysts.
Aly A, Matuschewski K
J Exp Med. 2005; 202(2):225-30.
PMID: 16027235
PMC: 2213010.
DOI: 10.1084/jem.20050545.
Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.
Sijwali P, Kato K, Seydel K, Gut J, Lehman J, Klemba M
Proc Natl Acad Sci U S A. 2004; 101(23):8721-6.
PMID: 15166288
PMC: 423262.
DOI: 10.1073/pnas.0402738101.
Apical membrane antigen 1, a major malaria vaccine candidate, mediates the close attachment of invasive merozoites to host red blood cells.
Mitchell G, Thomas A, Margos G, Dluzewski A, Bannister L
Infect Immun. 2003; 72(1):154-8.
PMID: 14688092
PMC: 343990.
DOI: 10.1128/IAI.72.1.154-158.2004.